Researchers within CAD investigate prevalence of cognitive problems in neurological and chronic diseases. Understanding how early identification of cognitive impairments impacts disease management and prognosis is a key focus area.
From exploring cognitive reserve after traumatic brain injury (TBI),stroke (SAB/CVA) and other neurological disorders to understanding cognitive disturbances in somatic disorders such as chronic kidney disease or cardiovascular diseases, CAD researchers examine the impact of diseases and disorders on cognitive functions. Additionally, they investigate cognitive decline following delirium and the decline in social cognition in neurological disorders and dementia.
CAD researchers delve into the effects of various medical treatments on cognitive domains, including chemotherapy, transplantation, dialysis, radiotherapy, and surgery. Our research aims to elucidate cognitive decline or preservation of cognition post-treatment and optimize patient care strategies and decision making.
The multidisciplinary approach of CAD within the Health in Context Research Institute holds great potential for advancing our understanding of disease-related cognitive decline and optimizing strategies for healthy aging and appropriate care.
Major CAD Research Themes are:
